NVCHI
MRNA icon

New Vernon Capital Holdings II’s Moderna MRNA Stock Holding History

New Vernon Capital Holdings II’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,623
Closed -$261K – 89
2023
Q4 		$261K Sell
2,623
-237
-8% -$19.9K 0.14% 64
2023
Q3 		$295K Buy
2,860
+423
+17% +$47.2K 0.26% 44
2023
Q2 		$296K Buy
2,437
+820
+51% +$109K 0.2% 43
2023
Q1 		$248K Buy
1,617
+11
+0.7% +$1.81K 0.18% 39
2022
Q4 		$288K Buy
1,606
+226
+16% +$37K 0.23% 26
2022
Q3 		$163K Sell
1,380
-1,118
-45% -$170K 0.17% 39
2022
Q2 		$357K Buy
+2,498
New +$357K 0.29% 19

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

New Vernon Capital Holdings II's MRNA Position: Q1 2024 in Review

New Vernon Capital Holdings II sold out of Moderna (MRNA) in Q1 2024, closing a stake of 2,623 shares — an estimated $261K sold.

New Vernon Capital Holdings II first reported a position in MRNA in Q2 2022 and held it in 7 quarters. The position peaked at $357K in Q2 2022. 903 funds tracked by Wall St. Rank hold MRNA as of Q1 2024.

  • New Vernon Capital Holdings II reported no remaining Moderna position as of Q1 2024 after selling out during the quarter.
  • New Vernon Capital Holdings II sold 2,623 Moderna shares in Q1 2024, an estimated $261K.
  • New Vernon Capital Holdings II first reported a position in Moderna in Q2 2022 and held it in 7 quarters.
  • New Vernon Capital Holdings II's Moderna position peaked at $357K in Q2 2022.
  • 903 funds tracked by Wall St. Rank held Moderna as of Q1 2024.

Based on New Vernon Capital Holdings II's 13F filing for Q1 2024, filed 15 May 2024.